natgillin/translations-raw huggingface dataset:
For dosing recommendations with HIV antiviral agents, refer to section 4.4 (Treatment of patients with HIV co-infection) and section 4.5. See section 5.1 for additional information.
Za priporočila o odmerjanju s protivirusnimi zdravili proti HIV glejte poglavje 4.4 (Zdravljenje bolnikov, sočasno okuženih s HIV) in poglavje 4.5. Za dodatne informacije glejte poglavje 5.1.
For dosing recommendations with HIV antiviral agents, refer to sections 4.4 and 4.5. See sections 4.8 and 5.1 for additional information.
Za priporočila o odmerjanju s protivirusnimi zdravili proti HIV glejte poglavji 4.4 in 4.5. Za dodatne informacije glejte poglavji 4.8 in 5.1.
For dosing, an oral dispenser with 30 mg, 45 mg and 60 mg graduations is provided in the box.
Za odmerjanje je v škatli priložen peroralni odmernik z oznakami za 30-mg, 45-mg in 60-mg.
For dulaglutide 0.75 mg, adverse reaction met frequency for next lower incidence grouping.
Za dulaglutid v odmerku 0,75 mg je neželeni učinek ustrezal pogostnosti za naslednjo najnižjo razvrstitev po incidenci.
For Dupuytren’s contracture, the doctor injects the appropriate dose of Xiapex directly into a cord in the patient’s palm.
Za zdravljenje Dupuytrenove kontrakture zdravnik injicira ustrezen odmerek zdravila Xiapex neposredno v vozlič v bolnikovi dlani.
For Dupuytren’s disease, Xiapex breaks down the collagen forming the cord and thereby releasing the contracture completely or partly and enabling your finger(s) to be straighter.
Pri Dupuytrenovi bolezni zdravilo Xiapex razgradi kolagen, ki tvori vozlič, in s tem kontrakturo povsem ali delno sprosti ter omogoči prstu(om), da so bolj ravni.
For DVT and pulmonary embolism, Xarelto was compared with enoxaparin given in combination with a vitamin K antagonist, VKA, in two main studies in 3,449 patients with acute DVT and 4,833 patients with pulmonary embolism, respectively.
Pri DVT in pljučni emboliji so zdravilo Xarelto v dveh glavnih študijah primerjali z enoksaparinom, ki so ga bolniki jemali v kombinaciji z antagonistom vitamina K (VKA) , pri čemer je v eni sodelovalo
For DVT/PE the recommendation for the use of Pradaxa 220 mg taken as one 110 mg capsule twice daily is based on pharmacokinetic and pharmacodynamic analyses and has not been studied in this clinical setting.
Priporočilo o uporabi zdravila Pradaxa v odmerku po 220 mg pri GVT/PE, ki ga bolnik vzame kot eno kapsulo po 110 mg dvakrat na dan, temelji na farmakokinetičnih in farmakodinamičnih analizah, saj v takšnih kliničnih razmerah še ni raziskano.
For E. coli, Campylobacter and Enterococci, both wild type and non-wild type phenotypes were observed (MIC range 1– > 64 µg/ml).
Za E. coli, Campylobacter in Enterococci,so bili ugotovljeni divji in nedivji fenotipi (razpon MIK 1.>64 µg/ml).
For E. coli, Campylobacter and Enterococci, both wild type and non-wild type phenotypes were observed (MIC range 1–> 64 µg/ml).
Za E. coli, Campylobacter in Enterococci, so bili ugotovljeni divji in nedivji fenotipi (razpon MIK 1>64 µg/ml).
For each dose of EMEND, you will get a pre-filled oral dispenser that contains the child’s prescribed dose.
Za vsak odmerek zdravila EMEND boste dobili napolnjen odmernik, ki vsebuje predpisani odmerek za otroka.
For each dose of Isentress you will need the following:
Za pripravo vsakega odmerka zdravila Isentress boste potrebovali naslednje:
For each gram of sodium phenylbutyrate, the granules contain 124 mg (5.4 mmol) of sodium and 768 mg of sucrose.
Na vsak gram natrijevega fenilbutirata zrnca vsebujejo 124 mg (5,4 mmol) natrija in 768 mg saharoze.
For each inhalation session with the I-Neb AAD, the content of one 1 ml ampoule of Ventavis 10 microgram/ml, with two coloured rings (white - yellow), is transferred into the medication chamber immediately before use.
Za vsako inhalacijo z nebulatorjem I-Neb AAD se vsebina ene 1-mililitrske ampule zdravila Ventavis 10 mikrogramov/ml, označena z dvema barvnima obročema (bel–rumen), neposredno pred uporabo prenese v prostor za zdravilo v nebulatorju.
For each inhalation session with the I-Neb AAD, the content of one 1 ml ampoule of Ventavis, with two coloured rings (white - yellow) is transferred into the medication chamber immediately before use.
Za vsako inhalacijo z nebulatorjem I-Neb AAD se vsebina ene 1-mililitrske ampule zdravila Ventavis, označena z dvema barvnima obročema (bel–rumen), neposredno pred uporabo prenese v prostor za zdravilo.
For each inhalation session with the I-Neb AAD, the content of one 1-ml ampoule of Ventavis 20 microgram/ml, showing two coloured rings (–yellow-red), will be transferred into the appropriate nebuliser medication chamber with golden coloured latch together with the golden colour disc immediately before use.
Za vsako inhalacijo z nebulatorjem I-Neb AAD se vsebina ene 1-mililitrske ampule zdravila Ventavis 20 mikrogramov/ml, označena z dvema barvnima obročema (rumen-rdeč), neposredno pred uporabo prenese v ustrezen prostor za zdravilo v nebulatorju z zlatim zapahom in zlatim nadzornim diskom.
For each inhalation session, the content of one ampoule containing 2 ml of Ventavis 10 microgram/ml nebuliser solution and marked with two coloured rings (white – pink) is transferred into the nebuliser medication chamber immediately before use.
Za vsako inhalacijo se vsebina ene 2-mililitrske ampule Ventavis 10 mikrogramov/ml inhalacijske raztopine za nebulator, označena z dvema barvnima obročema (bel-rožnat) neposredno pred uporabo prenese v prostor za zdravilo v nebulatorju.
For each injection site, one syringe of 1 ml with clear volume marks of 0.5 ml must be used.
Za vsako mesto injiciranja je treba uporabiti eno 1-ml injekcijsko brizgo z jasnimi oznakami za prostornino po 0,5 ml.
For each injection, follow steps 4 - 10.
Za vsako injekcijo sledite korakom 4 – 10.
For each medication chamber there is a corresponding colour coded control disc.
Vsak prostor za zdravilo je označen z barvno oznako in ima nadzorni disk, označen z ustrezno barvo.
For each medication chamber there is a corresponding colour coded control disc:
Za vsak prostor za zdravilo obstaja z ustrezno barvo označen nadzorni disk:
For each of the seven common serotypes, > 96% and > 90% of the Prevenar 13 recipients reached an OPA titre ≥ 1:8 one month after the primary series in studies 006 and 004, respectively.
Za vsakega od 7 skupnih serotipov je > 96 % prejemnikov cepiva Prevenar 13 v študiji 006 in > 90 % prejemnikov cepiva Prevenar 13 v študiji 004 doseglo titre OPA
For each of the seven common serotypes, > 96% and >90 % of the Prevenar 13 recipients reached an OPA titre ≥ 1:8 one month after the primary series in studies 006 and 004, respectively.
Za vsakega od 7 skupnih serotipov je > 96 % prejemnikov cepiva Prevenar 13 v študiji 006 in > 90 % prejemnikov cepiva Prevenar 13 v študiji 004 doseglo titre OPA
For each of the seven serotypes in common, 87.7% to 100% of Synflorix vaccinees and 92.1% to 100% of 7-valent Prevenar vaccinees reached an OPA titre  8 one month after the third dose.
En mesec po tretjem odmerku je titer OPA  8 proti vsakemu od sedmih skupnih serotipov doseglo od 87,7 % do 100 % preiskovancev, cepljenih s cepivom Synflorix, in od 92,1 % do 100 % preiskovancev, cepljenih s 7-valentnim cepivom Prevenar.
For each of the two syringes:
Za vsako od obeh brizg:
For each organ, or group of organs, the absorbed doses have been calculated using the methodology developed by the MIRD (Medical Internal Radiation Dose).
Izračunani so absorbirani odmerki za vsak organ ali skupino organov z metodologijo MIRD (Medical Internal Radiation Dose).
For each patient, the radiation exposure must be justified by the likely benefit.
Pri vsakem bolniku morate izpostavljanje ionizirajočemu sevanju utemeljiti na osnovi verjetnih koristi.
For each strength, the chewable tablets are available in the following pack sizes: Carton with 1 blister of 1, 3 or 6 chewable tablets.
Za vsako jakost so žvečljive tablete pakirane v naslednjih velikostih pakiranja: Škatlica z 1 pretisnim omotom z 1, 3 ali 6 žvečljivimi tabletami.
For each strength, the chewable tablets are available in the following pack sizes: Carton with 1 thermoformed blister containing 1, 3 or 6 chewable tablets.
Za vsako jakost so žvečljive tablete pakirane v naslednjih velikostih pakiranja: Škatla z 1 pretisnim omotom z 1, 3 ali 6 žvečljivimi tabletami.
For each subsequent drop < 0.5 x 109/l
Pri vsakem nadaljnjem zmanjšanju
For each subsequent drop <25 x 109/l
Pri vsakem nadaljnjem zmanjšanju
For each subsequent drop below 1 x 109/L for at least 7 days or drop to < 1 x 109/L with associated fever (body temperature ≥ 38.5°C) or drop to < 0.5 x 109/L
pri vsakem nadaljnjem zmanjšanju pod 1 x 109/l za vsaj 7 dni ali zmanjšanju na < 1 x 109/l s
For each vial, the packs contain: one syringe pre-filled with sterile water for injection (solvent).
Pakiranje za vsako vialo vsebuje še: eno injekcijsko brizgo, napolnjeno s sterilno vodo za injekcije (vehikel).
For ECG and electrolytes abnormalities, see section 4.4.
Za anomalije EKG in elektrolitov glejte poglavje 4.4.
For ectoparasites a field study involved 324 dogs with flea and/or tick infestations that were given a single treatment with Nexgard Spectra or a spot-on medicine containing pyripole that controls fleas and ticks.
V terensko študijo, ki je obravnavala ektoparazite, je bilo vključenih 324 psov z infestacijo z bolhami in/ali klopi, ki so prejeli bodisi enkratno zdravljenje z zdravilom Nexgard Spectra ali zdravilo za kožni nanos s piripolom, ki služi za obvladovanje bolh in klopov.
For EE, slight increases were observed due to treadmill and other aerobic exercise; however, the Css values following these treatments were within the reference range.
Opazili so rahlo zvišanje vrednosti etinilestradiola pri hoji po tekočem traku in drugih aerobnih vajah, medtem ko so bile vrednosti Css podobne referenčnim.
for efavirenz when given with
indinavirja in efavirenza
for either medicinal product.
za nobeno od teh zdravil.
for either product
dajanja zdravil
For elderly 65 years af age or older the starting dose is 5 mg vortioxetine taken once daily.
Za starejše bolnike, stare 65 let ali več, je začetni odmerek 5 mg vortioksetina v enkratnem dnevnem odmerku.
For elderly patients and patients with renal or hepatic impairment see sections 4.3 and 4.4:
Za starejše bolnike in bolnike z okvaro ledvic ali jeter glejte poglavji 4.3 in 4.4.
For elderly patients weighing less than 50 kg and for patients with moderate liver problems, treatment is with half the usual recommended dose of Dynastat, with a maximum daily dose of 40 mg.
Starejše bolnike, ki tehtajo manj kot 50 kg, in bolnike z zmerno okvaro jeter je treba zdraviti s polovico običajno priporočenega odmerka zdravila Dynastat, pri čemer pa je najvišji dovoljeni dnevni odmerek 40 mg.
For elderly patients, although no dose adjustment is required the treatment should be carefully monitored and periodically re-assessed (see section 4.4).
Kljub temu, da odmerka pri starejših bolnikih ni potrebno spreminjati, je treba pozorno spremljati zdravljenje in ga občasno ponovno oceniti (glejte poglavje 4.4).
For elderly people 65 years af age or older the starting dose is 5 mg vortioxetine taken once daily.
Za starejše bolnike, stare 65 let ali več, je začetni odmerek 5 mg vortioksetina v enkratnem dnevnem odmerku.
For elderly people 65 years af age or older, the starting dose is 5 mg vortioxetine taken once daily.
Za starejše bolnike, stare 65 let ali več, je začetni odmerek 5 mg vortioksetina v enkratnem dnevnem odmerku.
For elderly persons (≥65 years) the first booster dose may be given earlier.
Starejši odrasli (≥ 65 let) lahko prvi obnovitveni odmerek prejmejo prej.
For ENABLE 1, 682 patients were randomised to the antiviral treatment phase; however 2 subjects then withdrew consent prior to receiving antiviral therapy. p-value < 0.05 for eltrombopag versus placebo
Pri ENABLE 1 je bilo 1682 bolnikov randomiziranih v fazo protivirusnega zdravljenja; vendar sta 2 bolnika odstopila pred začetkom protivirusnega zdravljenja vrednost P < 0,05 za eltrombopag glede na placebo
For endocarditis and for skin or soft tissue infection with bacteraemia, the dose is 6 mg/kg every 24 hours.
Pri endokarditisu ali okužbah kože oziroma mehkega tkiva z bakteremijo znaša odmerek 6 mg/kg vsakih 24 ur.
For endotracheopulmonary use.
Za endotraheopulmonalno uporabo.
For enthesitis-related arthritis in patients from the age of 12 years when other widely used treatments have not worked well enough or are not suitable for them
za zdravljenje artritisa, povezanega z entezitisom, pri bolnikih, starejših od 12 let, če zdravljenje z običajnimi oblikami zdravljenja ni bilo uspešno ali jih bolniki niso prenašali.
for epilepsy
pri epilepsiji
For epilesional use
epilezijska uporaba
For epilesional use.
za epilezijsko uporabo
For erectile dysfunction: Particular caution must be used when prescribing sildenafil or tadalafil in patients receiving Kaletra with increased monitoring for adverse events including hypotension, syncope, visual changes and prolonged erection (see section 4.4).
Za erektilno disfunkcijo: Bolnikom, ki jemljejo zdravilo Kaletra, je treba sildenafil ali tadalafil predpisovati posebno previdno in jih pogosteje kontrolirati glede neželenih učinkov, vključno s hipotenzijo, sinkopo, spremembami vida in dolgotrajno erekcijo (glejte poglavje 4.4).
For evaluable subjects enrolled in the prophylaxis fixed weekly interval arm of study I, the median weekly dose was 45.17 IU/kg (interquartile range 38.1-53.7).
Pri osebah, vključenih v profilaktični krak s fiksnim tedenskim intervalom študije I, ki jih je bilo mogoče oceniti, je bila mediana tedenskega odmerka 45,17 i.e./kg (interkvartilni razpon 38,1-53,7).
For evaluable subjects enrolled in the prophylaxis individualised interval arm of study I, the median interval was 12.53 days (interquartile range 10.4-13.4).
Pri osebah, vključenih v profilaktični krak z individualiziranim intervalom študije I, ki jih je bilo mogoče oceniti, je bila mediana intervala 12,53 dneva (interkvartilni razpon 10,4-13,4).
For every 2 kg (4 lb) you lose from dieting alone, alli can help you lose 1 kg (2 lb) more.
Za vsaka 2 kg, ki bi ju izgubili samo z dieto, vam zdravilo alli lahko pomaga izgubiti 1 dodaten kilogram.
For every following injection
Pri vsakem nadaljnjem injiciranju
For example bexarotene may reduce the efficacy of oral contraceptives (see sections 4.4 and 4.6).
Beksaroten lahko na primer zmanjša učinkovitost peroralnih kontracepcijskih sredstev (glejte poglavje 4.4 in 4.6).
For example, a dose of 140 mg docetaxel would require 7 ml docetaxel concentrate for solution for infusion.
Na primer, za odmerek 140 mg docetaksela je potrebno 7 ml koncentrata za razopino za infundiranje z docetakselom.
For example, a dose of 140 mg docetaxel would require 7 ml docetaxel concentrate for solution.
Na primer: za odmerek 140 mg docetaksela bi potrebovali 7 ml koncentrata za raztopino docetaksela.
For example, a dose of 140 mg docetaxel would require 7 ml Taxespira 20 mg/1 ml concentrate for solution for infusion.
Na primer, za odmerek 140 mg docetaksela bi bilo potrebnih 7 ml zdravila Taxespira20 mg/ 1 ml koncentrat za raztopino za infundiranje.
For example, a dose of 140 mg docetaxel would require one 80 mg and three 20 mg packs.
Na primer, za odmerek od 140 mg docetaksela bo potreben en 80 miligramskoi pakiranje in tri 20 miligramska pakiranja.
For example, a dose of 140 mg docetaxel would require one 80 mg pack and three 20 mg packs.
Primer: za odmerek 140 mg docetaksela bi potrebovali eno 80-miligramsko pakiranje in tri 20-miligramska pakiranja.
For example, a patient taking one tablet of 100 mg/25 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 100 mg/25 mg/200 mg Corbilta tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 100 mg/25 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 100 mg/25 mg/200 mg tableto zdravila Corbilta 4-krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 100 mg/25 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 100 mg/25 mg/200 mg Levodopa/Carbidopa/Entacapone Orion tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 100 mg/25 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 100 mg/25 mg/200 mg tableto zdravila Levodopa/Carbidopa/Entacapone Orion 4-krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 100 mg/25 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 100 mg/25 mg/200 mg Stalevo tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 100 mg/25 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 100 mg/25 mg/200 mg tableto zdravila Stalevo 4- krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 150 mg/37.5 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 150 mg/37.5 mg/200 mg Corbilta tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 150 mg/37,5 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 150 mg/37,5 mg/200 mg tableto zdravila Corbilta 4-krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 150 mg/37.5 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 150 mg/37.5 mg/200 mg Levodopa/Carbidopa/Entacapone Orion tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 150 mg/37,5 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 150 mg/37,5 mg/200 mg tableto zdravila Levodopa/Carbidopa/Entacapone Orion 4-krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 150 mg/37.5 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 150 mg/37.5 mg/200 mg Stalevo tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 150 mg/37,5 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 150 mg/37,5 mg/200 mg tableto zdravila Stalevo 4-krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 200 mg/50 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 200 mg/50 mg/200 mg Corbilta tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 200 mg/50 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 200 mg/50 mg/200 mg tableto zdravila Corbilta 4-krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 200 mg/50 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 200 mg/50 mg/200 mg Levodopa/Carbidopa/Entacapone Orion tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 200 mg/50 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 200 mg/50 mg/200 mg tableto zdravila Levodopa/Carbidopa/Entacapone Orion 4-krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, a patient taking one tablet of 200 mg/50 mg of levodopa/carbidopa with one tablet of entacapone 200 mg four times daily can take one 200 mg/50 mg/200 mg Stalevo tablet four times daily in place of their usual levodopa/carbidopa and entacapone doses.
Na primer bolnik, ki prejema po eno tableto 200 mg/50 mg levodope/karbidope z eno tableto entakapona 200 mg 4-krat dnevno, lahko jemlje eno 200 mg/50 mg/200 mg tableto zdravila Stalevo 4- krat dnevno namesto običajnih odmerkov levodope/karbidope in entakapona.
For example, after two weeks of GnRH agonist treatment, 150 to 225 IU
Na primer, po dveh tednih zdravljenja z agonistom GnRH se
For example, following two weeks of treatment with an agonist, 150-225 IU follitropin alfa are administered for the first 7 days.
Na primer, po dvotedenskem zdravljenju z agonistom se prvih 7 dni daje 150–225 i.e. folitropina alfa.
For example, for a baby with a body weight of 3 kg, the calculation becomes: (3 x 0.15) mL = 0.45 mL palivizumab per month
Na primer, za dojenčka s telesno maso 3 kg velja naslednji izračun: (3 x 0,15) ml = 0,45 ml palivizumaba na mesec
For example, for a baby with a body weight of 3 kg, the calculation becomes: (3 x 0.15) mL = 0.45 mL palivizumab per month.
Na primer za dojenčka s telesno maso 3 kg velja naslednji izračun: (3 x 0,15) ml = 0,45 ml palivizumaba na mesec.
For example, if the prescribed dose is 0.5 ml, DO NOT push the white plunger rod past the 0.5 ml position.
Če je npr. predpisani odmerek 0,5 ml, NE POTISNITE belega nosilca bata čez položaj 0,5 ml.
For example, if you need 31 units and only 25 units remain in the cartridge you will not be able to dial past 25.
Na primer, če potrebujete 31 enot in jih je v vložku ostalo samo še 25, ne boste mogli nastaviti preko 25.
For example, if you start on a Wednesday, use the day label sticker that starts with ‘WED’.
Če na primer začnete kontracepcijske tablete jemati v sredo, uporabite tisto nalepko z dnevnimi oznakami, ki se začne s "SRE".
For example, if your dose is 30 ml, you need to take 3 syringe-fulls of medicine
Na primer če je vaš odmerek 30 ml, morate vzeti 3 napolnjene brizge z zdravilom.
For example, if your last injection was in your left thigh, your next injection should be in your right thigh, your abdomen, or the back of either arm.
Na primer: če ste si nazadnje injicirali zdravilo v levo stegno, si morate naslednjo injekcijo dati v desno stegno, trebuh ali nadlaket.
For example, in the timing of the injections in relation to meals.
Na primer, kar zadeva čas injiciranja glede na obroke.
For example, inject on the first Monday of each month.
Na primer, injicirajte si ga prvi ponedeljek vsakega meseca.
For example, one sachet of 40 g is sufficient to treat a total of 1,000 birds with an average bodyweight of 1 kg; one sachet of 400 g is sufficient to treat a total of 10,000 birds with an average bodyweight of 1 kg.
Ena 40-gramska vrečica na primer zadostuje za zdravljenje skupno 1000 ptic s povprečno telesno težo 1 kg; ena 400-gramska vrečica na primer zadostuje za zdravljenje skupno 10,000 ptic s povprečno telesno težo 1 kg.
For example, one sachet of 40 g is sufficient to treat a total of 1,000 birds with an average bodyweight of 1 kg; one sachet of 400 g is sufficient to treat a total of 10,000 birds with an average bodyweight of 1kg.
Ena 40-gramska vrečica na primer zadostuje za zdravljenje skupno 1000 ptic s povprečno telesno težo 1 kg; ena 400-gramska vrečica na primer zadostuje za zdravljenje skupno 10,000 ptic s povprečno telesno težo 1 kg.
For example, the body weight dosing used in conjunction with interferon alfa-2b or peginterferon alfa-2b is shown in Table 1.
Na primer, telesna masa, upoštevana pri kombiniranem zdravljenju z interferonom alfa-2b ali peginterferonom alfa- 2b je prikazana v Preglednici 1.
For example, the formation of antibodies (also known as inhibitors) to factor IX is a known complication that can occur during the treatment of haemophilia B. The antibodies prevent the treatment from working properly.
Nastajanje protiteles (znanih tudi kot zaviralci) proti faktorju IX je na primer znan zaplet, ki se lahko pojavi med zdravljenjem hemofilije B. Protitelesa preprečujejo pravilno delovanje zdravljenja.